SynthesisActa diabetologica2023

Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.

Alhassane Diallo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.